Nosca-Méréprine (Noscapine Hydrochloride Monohydrate)

Noscapine Hydrochloride Monohydrate, the active ingredient in Nosca-Méréprine, is an antitussive presented as an oral dosage form for oral use. It suppresses cough by acting on the central nervous system and is employed in patients requiring symptomatic relief of non‑productive cough and is suitable for adult patients.

GNH USA supplies Nosca-Méréprine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers across multiple regions.

Nosca-Méréprine (noscapine) is used as an antitussive to suppress the cough reflex.

- Cough (non‑productive): reduces the frequency and intensity of a dry cough. - Acute bronchitis (dry cough): helps alleviate coughing associated with bronchial inflammation. - Post‑viral cough: assists in relieving lingering cough after viral upper‑respiratory infections.

Adverse reactions may occur with any antitussive medication.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Drowsiness: feeling of sleepiness. - Headache: mild cranial discomfort. - Gastrointestinal upset: abdominal discomfort or mild diarrhea. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Hematologic effects: neutropenia or thrombocytopenia. - Seizures: rare occurrence of convulsive episodes.

When prescribing Nosca-Méréprine, clinicians should consider several safety aspects.

- Pregnancy: safety not established; use only if potential benefit justifies the risk. - Breastfeeding: unknown excretion; consider alternative therapy. - Renal impairment: monitor renal function and adjust if necessary. - Hepatic impairment: use with caution; monitor liver enzymes. - Drug interactions: review all concomitant medications for possible interactions. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Nosca-Méréprine may interact with other medicines; awareness of interaction severity helps guide monitoring.

Major Interactions (Avoid): - Opioid antitussives: additive central nervous system depression. - Monoamine oxidase inhibitors (MAOIs): risk of severe adverse reactions. - Sedating antihistamines: increased drowsiness.

Moderate Interactions (Monitor Closely): - CYP450 substrates: noscapine may alter metabolism of drugs processed by these enzymes. - Anticholinergic agents: may exacerbate dry mouth or constipation.